Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Tuthill

Showing results (31-40 of 41) with videos related to

Pageof 5
Sort By:
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
JU Open Plus|March 12, 2026
Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort StudyMatthew H V Byrne, Nithesh Ranasinha, Abhishek Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
BJU International|February 26, 2026
The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical careAbhishek Sharma, Teresa Campbell, Sagar Kanabar, et al.
Gastroenterology|June 20, 2021
Interferon-Gamma-Producing CD8<sup>+</sup> Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-ColitisSarah C Sasson, Stephanie M Slevin, Vincent T F Cheung, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
Ebiomedicine|January 5, 2023
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decadeM Alvaro Berbís, David S McClintock, Andrey Bychkov, et al.
Journal of Pathology Informatics|May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathologyJoshua Pantanowitz, Christopher D Manko, John Majewski, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 5

Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
BMJ Open|January 20, 2025
Adaptive clinical trial of AZD7442 and SARS-CoV-2 vaccination in immunosuppressed patients highly vulnerable to infection with SARS-CoV-2 virus (RAPID-PROTECTION): protocol for a multicentre, interventional open-label, randomised controlled trialMelanie Varley, Joanne Euden, Richard Adams, et al.
JU Open Plus|March 12, 2026
Flourine-18 Prostate-Specific Membrane Antigen-1007 Positron Emission Tomography Imaging in Staging of Primary and Secondary Prostate Cancer-A Retrospective Observational Cohort StudyMatthew H V Byrne, Nithesh Ranasinha, Abhishek Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 6, 2023
Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM)Naveen S Vasudev, Gemma Ainsworth, Sarah Brown, et al.
Diagnostics (Basel, Switzerland)|December 24, 2021
Digital Pathology Transformation in a Supraregional Germ Cell Tumour NetworkRichard Colling, Andrew Protheroe, Mark Sullivan, et al.
BJU International|February 26, 2026
The PRAGMATIC pathway - PRostate cancer diAGnosis and MAnagement Triage In Clinical careAbhishek Sharma, Teresa Campbell, Sagar Kanabar, et al.
Gastroenterology|June 20, 2021
Interferon-Gamma-Producing CD8<sup>+</sup> Tissue Resident Memory T Cells Are a Targetable Hallmark of Immune Checkpoint Inhibitor-ColitisSarah C Sasson, Stephanie M Slevin, Vincent T F Cheung, et al.
The Lancet. Oncology|September 13, 2020
Circulating tumour DNA analysis to direct therapy in advanced breast cancer (plasmaMATCH): a multicentre, multicohort, phase 2a, platform trialNicholas C Turner, Belinda Kingston, Lucy S Kilburn, et al.
Ebiomedicine|January 5, 2023
Computational pathology in 2030: a Delphi study forecasting the role of AI in pathology within the next decadeM Alvaro Berbís, David S McClintock, Andrey Bychkov, et al.
Journal of Pathology Informatics|May 21, 2026
How does AI perform compared to human expert panels in medical Delphi studies? A pilot study through the lens of pathologyJoshua Pantanowitz, Christopher D Manko, John Majewski, et al.
JAMA Oncology|December 22, 2022
Association of SARS-CoV-2 Spike Protein Antibody Vaccine Response With Infection Severity in Patients With Cancer: A National COVID Cancer Cross-sectional EvaluationLennard Y W Lee, Michael Tilby, Thomas Starkey, et al.
Pageof 5